Analytical Cellular Pathology
Journal of the European Society for Analytical Cellular Pathology

In 2010, Analytical Cellular Pathology will be published jointly with Cellular Oncology.

ISSN: 0921-8912
Volume 32-33; 12 issues
Institutional subscription (print and online) for 2010: €1464 / US$2120 (including postage and handling)
Click on the subscribe button for more options, including personal subscription prices.
Status Report:

Aims and Scope
Submission of Manuscripts
Download flyer for this journal

Submission of Manuscripts 
Please contact for information.
Aims and Scope 
IOS Press is pleased to inform you that from 2010 onwards, the journal Analytical Cellular Pathology (ACP, ISSN 0921-8912) will be recommenced. The journal ACP changed its title and scope in 2005 and was replaced by the journal Cellular Oncology (CLO, ISSN 1570-5870). CLO will be published as part of a combined journal with Analytical Cellular Pathology as of 2010. The issues will contain a mix of articles that reflect the expanded scope of ACP as well as contents of the current CLO journal. The number of issues will be doubled to 12 in 2010.

Cellular Oncology has an Impact Factor of 3.383 (2008) according to Thomson Reuters' Journal Citation Reports 2009. The last Impact Factor for Analytical Cellular Pathology was 3.053 (2004 ).

Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype–phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology will form a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologist and other clinicians involved in the management of cancer patients.

Cellular Oncology publishes original papers, rapid communications, topical reviews, technical notes, special reports and letters.

Analytical Cellular Pathology publishes scientific articles from various disciplines that focus on quantitative aspects of pathology. The emphasis is on the application of physical techniques to the study of cells, tissues, and organs in disease. Pathology initially evolved largely as a qualitative image-based discipline, with some forays into computer-based cytometry and morphometry. More recently, the flourishing of molecular biology has led to a paradigm shift that has changed this approach and rejuvenated our field. The convergence of biomedicine, bioengineering, and sophisticated new tools of mathematical analysis has the potential for yet another revolution towards a more precise and analytic discipline.

Scientists studying fundamental aspects of pathogenesis as well as those interested in translational diagnostic research are increasingly embracing such tools as biomedical photonics, surface resonance phenomena, and impedance tomography, as well as new approaches for ultra-high resolution magnetic resonance. Examples of appropriate articles include those dealing with electromechanical properties of cells utilizing these methodologies as well as multispectral, hyperspectral, and vibrational mode analysis, and a variety of other ways of exploring biophysical manifestations of disease processes. These articles may also be based on computational biology models, but in all cases should be accessible to, and of interest to an audience consisting of pathologists, cell biologists, and biochemists as well as biomedical engineers. In other words, it is the contribution to the study of pathologic processes that should be emphasized rather than methodological details per se.

The overall intent is to focus on the application of physical techniques, not only for the investigation of fundamental issues of pathogenesis but also for translational diagnostic research. These latter should be based on novel concepts, novel methodologies or the novel use of existing methodologies that can lead to enhanced prognosis as well as therapeutic guidance for the fully personalized and tailored medicine of the future.

IOS Press
Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands
Tel.: +31 20 688 3355, Fax: +31 20 687 0019